Definitive Contract HHSN272201600039C
Award Date
7/28/16
Potential Completion Date
8/25/18
Potential Value
$450K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
KJ Biosciences LLC
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
10
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
The federal contract award 75N93019C00029 was granted to KJ Biosciences LLC, a minority-owned, for-profit limited liability company, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, on September 16, 2019. The $2,944,331.33 cost-plus-fixed-fee contract is for the Phase II advanced development of a novel nanoparticle conjugate vaccine for Salmonella Paratyphi A, under the Small Business Innovation Research (SBIR) program. The contract has a completion date...
This $299,040 firm-fixed-price Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The objective is to design and synthesize a new PLGA-based nanoparticle with an optimal protein-adjuvant formulation that combines targeting and controlled delivery for immunization...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $298,596 definitive contract to Sanaria Inc. of Potomac, MD for Research Type Small Business Innovation Research Program Phase I Action. The contract is a firm fixed price award with a period of performance from August 30, 2022 through April 1, 2024. The place of performance is Potomac, MD and the contract has a total small business set aside...
This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases to Teichos Laboratories, LLC, a small business located in West Lafayette, IN. The $300,000 firm fixed price contract is for research on a novel TLR2 agonist-aluminum combination adjuvant to improve the quality and duration of the immune response. This SBIR contract was awarded under a solicitation that sought innovative...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This is a $999,997.00 firm fixed-price SBIR Phase II R&D contract awarded by the Defense Health Agency (DHA) to Sanaria Inc., a small business veteran-owned manufacturer. The contract is for the "Delivery System for Cryopreserved Eukaryotic Cell Vaccines," supporting Sanaria's work on an investigational malaria vaccine using Plasmodium falciparum sporozoites. Sanaria has previously received federal funding for malaria vaccine research, development, and manufacturing from agencies...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
This is a $219,779.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Wave 80 Biosciences, Inc., a for-profit small business manufacturer located in San Francisco, California. The contract was awarded on September 3, 2013 and has a completion date of September 29, 2014. The contract is a firm fixed-price definitive contract,...
This is a $450,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) to Versatope Therapeutics Inc., a for-profit biotechnology company. The contract is for the development of a novel adjuvant for a malaria vaccine, using Versatope's recombinant outer membrane vesicle (ROMV) technology. The original solicitation was part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR Program, which seeks to stimulate...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Neovaxsyn Inc., a minority-owned small disadvantaged business located in Ames, Iowa. The $300,000 firm-fixed-price contract supports the development of innovative HIV/AIDS vaccine technologies, including the use of nanoparticle delivery systems and strategies to induce broadly...